Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 6/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14759196 | 0.94 | NAAA (0.50) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL25226358 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL14759435 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL25229297 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL65775 | 0.91 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL25226108 | 0.89 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| Ammonia Solution, Strong SCHEMBL28649190 | 0.89 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL25229268 | 0.88 | NAAA (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL721996 | 0.88 | NAAA (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL534600 | 0.88 | NAAA (0.48) | ALDH1A1ATMTSHRHPGDHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-11291659-B2 | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | Fulcrum Therapeutics, Inc. (US) | 2022-04-05 | — | — | US | disclosed |
| EP-2568019-B1 | Inkjet ink | JNC CORP (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-9040625-B2 | Water/oil repellent composition, method for its production and article | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-05-26 | — | — | US | disclosed |
| EP-2703466-A1 | WATER-REPELLENT AND OIL-REPELLENT AGENT COMPOUND, MANUFACTURING METHOD THEREFOR, AND ARTICLE | Asahi Glass Company, Limited (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20140051797-A1 | WATER/OIL REPELLENT COMPOSITION, METHOD FOR ITS PRODUCTION AND ARTICLE | ASAHI GLASS COMPANY, LIMITED (JP) | 2014-02-20 | — | — | US | disclosed |
| EP-2568019-A1 | Inkjet ink | JNC Corporation (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-0575191-B1 | Non-aqueous electrolyte solvent and battery containing this electrolyte | MITSUI PETROCHEMICAL IND (JP) | 1997-08-27 | — | — | EP | disclosed |
| US-5385794-A | Lithium battery; carbamate and cyclic carbonate solvents | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0575191-A1 | Non-aqueous electrolyte solvent and battery containing this electrolyte | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1993-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291659-B2 | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | ZFX, TBL1XR1, TRIM28 | ALDH1A1 4699/4885ATM 2042/4885TSHR 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.